Amgen Inc. ( AMGN ) will begin trading ex-dividend on May 13, 2016. A cash dividend payment of $1 per share is scheduled to be paid on June 08, 2016. Shareholders who purchased AMGN prior to the ex-dividend date are eligible for the cash dividend payment. This represents an 26.58% increase over the same period a year ago. At the current stock price of $154.18, the dividend yield is 2.59%.
The previous trading day's last sale of AMGN was $154.18, representing a -15.2% decrease from the 52 week high of $181.81 and a 18.52% increase over the 52 week low of $130.09.
AMGN is a part of the Health Care sector, which includes companies such as Gilead Sciences, Inc. ( GILD ) and Biogen Inc. ( BIIB ). AMGN's current earnings per share, an indicator of a company's profitability, is $9.46. Zacks Investment Research reports AMGN's forecasted earnings growth in 2016 as 7.8%, compared to an industry average of 3.1%.
Interested in gaining exposure to AMGN through an Exchange Traded Fund [ETF]?
The following ETF(s) have AMGN as a top-10 holding:
- iShares Nasdaq Biotechnology Index Fund ( IBB )
- PowerShares Dynamic Biotech &Genome ( PBE )
- PowerShares Dynamic Pharmaceuticals ( PJP )
- SPDR Select Sector Fund - Health Care ( XLV )
- VanEck Vectors Biotech ETF ( BBH ).
The top-performing ETF of this group is XLV with an decrease of -3.99% over the last 100 days. IBB has the highest percent weighting of AMGN at 8.72%.